Familial Investigations of Childhood Cancer Predisposition
Public ClinicalTrials.gov record NCT03050268. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT03050268
- Recruitment status
- Recruiting
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- St. Jude Children's Research Hospital
- Other
- Enrollment
- 1,500 participants
Conditions and interventions
Conditions
- AML
- Acute Leukemia
- Adenomatous Polyposis
- Adrenocortical Carcinoma
- BAP1 Tumor Predisposition Syndrome
- Carney Complex
- Choroid Plexus Carcinoma
- Constitutional Mismatch Repair Deficiency Syndrome
- DICER1 Syndrome
- Diamond-Blackfan Anemia
- Dyskeratosis Congenita
- Emberger Syndrome
- Familial Acute Myeloid Leukemia
- Familial Adenomatous Polyposis
- Familial Cancer
- Familial Neuroblastoma
- Familial Wilms Tumor
- Fanconi Anemia
- GIST
- Hereditary Breast and Ovarian Cancer
- Hereditary Paraganglioma-Pheochromocytoma Syndrome
- Hodgkin Lymphoma
- Juvenile Polyposis
- Li-Fraumeni Syndrome
- Lynch Syndrome
- MDS
- Melanoma Syndrome
- Multiple Endocrine Neoplasia Type 1
- Multiple Endocrine Neoplasia Type 2
- Neuroblastoma
- Neurofibromatosis Type 1
- Neurofibromatosis Type II
- Nevoid Basal Cell Carcinoma Syndrome
- Non Hodgkin Lymphoma
- Noonan Syndrome and Other Rasopathy
- Overgrowth Syndromes
- PTEN Hamartoma Tumor Syndrome
- Pancreatic Cancer
- Peutz-Jeghers Syndrome
- Pheochromocytoma/Paraganglioma
- Retinoblastoma
- Rhabdoid Tumor Predisposition Syndrome
- Rhabdomyosarcoma
- Rothmund-Thomson Syndrome
- Tuberous Sclerosis
- Von Hippel-Lindau Disease
Interventions
Not listed
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 5, 2017
- Primary completion
- Mar 30, 2037
- Completion
- Mar 30, 2037
- Last update posted
- Apr 22, 2026
2017 – 2037
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| St. Jude Children's Research Hospital | Memphis | Tennessee | 38105 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03050268, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 22, 2026 · Synced May 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03050268 live on ClinicalTrials.gov.